However, in the current study, we found a relatively higher concentration of adropin in patients with T2DM (2.58 ± 0.8 ng/mL); which may be contributory to the low number of included studies in our previous study (n = 5), and a wide interval of reported values, which may not be a true representation of the obese population. The gene discussed is ENHO; the disease is type 2 diabetes mellitus.